Cannabis
Rapid Dose Therapeutics Completes QuickStrip™ Equipment Installation in Puerto Rico and Grants Stock Options
Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the installation of its QuickStripproduction equipment at Chemesis International Inc. (“Chemesis”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is now complete, enabling the immediate recognition of revenue to RDT under the Managed Strip Services Agreement signed in October 2018 (the “Agreement”).
Under the Agreement, Chemesis has been granted the right to manufacture, distribute and sell RDT’s QuickStrip innovative, proprietary delivery technology products to the cannabis market in the US Territory of Puerto Rico.
RDT’s proprietary QuickStrip technology is a Quick, Convenient, Precise, Discreet oral fast-dissolving drug delivery system providing cannabis consumers a smoke-free alternative, while simultaneously offering health benefits and improving patient outcomes.
“RDT remains committed to providing global consumers in the cannabis markets a Smoke-Free Choice that they can consume Anytime, Anywhere. As these markets evolve and expand, RDT will be at the forefront of innovative cannabis delivery,” said Mark Upsdell, CEO of RDT. “We are pleased to have Chemesis as our partner in Puerto Rico, which further strengthens and positions QuickStrip as a growing international brand and delivery device,” added Upsdell.
RDT also announced the grant of options to an officer and employees to purchase 1,100,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or before July 29, 2024. The grants are subject to the terms of RDT’s stock option plan. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to a resale restriction for a period of four months from the date of the grant.
SOURCE Rapid Dose Therapeutics Corp.
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan7 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis3 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis3 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis1 day ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032